Geneva, Oct. 15 -- International Clinical Trials Registry received information related to the study (ChiCTR2600133931) titled 'Multicenter Retrospective Analysis of EBV Antibodies Detected via Chemiluminescence for Early Auxiliary Diagnosis of Nasopharyngeal Carcinoma' on Oct. 9.
Study Type: Observational study
Study Design:
Case-Control study
Primary Sponsor: The Second Affiliated Hospital of Guangxi Medical University
Condition:
Nasopharyngeal carcinoma (NPC)
Intervention:
Control Group (Healthy Control Group, HC):None
Recruitment Status: Recruiting
Phase: N/A
Date of First Enrollment: 2026-06-01
Target Sample Size: Control Group (Healthy Control Group, HC):150;Case group (Nasopharyngeal carcinoma, NPC):150;
Countries o...